|
KMID : 1148920190530010035
|
|
Nuclear Medicine and Molecular Imaging
2019 Volume.53 No. 1 p.35 ~ p.37
|
|
|
Activities for the Development of Targeted Radionuclide Therapy in Japan
|
|
Kinuya Seigo
|
|
|
Abstract
|
|
|
|
Targeted radionuclide therapy (TRT) is unique because of its efficacy and its theranostic feature in the era of precision medicine. So far, introduction of new TRT has not been going well in Japan due to several reasons including strict regulations, shortage of facilities for TRT, and insufficient reimbursement for TRT in clinic. Japanese community had several strategies to develop TRT in these 10 years, including the establishment of the National Conference for Nuclear Medicine Theranostics in which physicians, scientists, patients, people supporting patients, and industrial people gather. To promote TRT with supports from the government, the preparatory committee for the establishment of Japan Foundation of Medical Isotope Development (JAFMID) was launched. I would like to call TRT “Precision Nuclear Medicine.” When we can add genomic information here, we can put it to new stage of cancer therapy. It is time for us.
|
|
|
KEYWORD
|
|
|
Targeted radionuclide therapy, Theranostics, Japan, Governmental support
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|
|